Preexposure prophylaxis will have a limited impact on HIV-1 drug resistance in sub-Saharan Africa: a comparison of mathematical models
Preexposure prophylaxis (PrEP) with tenofovir and emtricitabine can prevent new HIV-1 infections, but there is a concern that use of PrEP could increase HIV drug resistance resulting in loss of treatment options. We compared standardized outcomes from three independent mathematical models simulating...
Główni autorzy: | van de Vijver, DAMC, Nichols, BE, Abbas, UL, Boucher, CAB, Cambiano, V, Eaton, JW, Glaubius, R, Katrina Lythgoe, Mellors, J, Phillips, A, Sigaloff, KC, Hallett, TB |
---|---|
Format: | Journal article |
Język: | English |
Wydane: |
Lippincott, Williams and Wilkins
2013
|
Podobne zapisy
-
AIDS vaccines and preexposure prophylaxis: is synergy possible?
od: Excler, J, i wsp.
Wydane: (2011) -
Potential for immune-driven viral polymorphisms to compromise antiretroviral-based preexposure prophylaxis for prevention of HIV-1 infection
od: Gatanaga, H, i wsp.
Wydane: (2017) -
Stroop interference for different preexposures of the word is affected in inhibition of return
od: Vivas, AB, i wsp.
Wydane: (2000) -
Mefloquine prophylaxis
od: ter Kuile, F, i wsp.
Wydane: (1993) -
Mefloquine prophylaxis.
od: ter Kuile, F, i wsp.
Wydane: (1993)